Centessa Pharmaceuticals plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 10/15/2024 | 19.96 M | $319.21 M | 0.00% | 17.17% |
| GENERAL ATLANTIC, L.P. | 11/12/2024 | 9.68 M | $154.81 M | 0.00% | 8.33% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 6.28 M | $100.45 M | 59.72% | 5.40% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2024 | 5.94 M | $94.98 M | 24.26% | 5.11% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 4.68 M | $74.82 M | 32.54% | 4.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 4.20 M | $67.08 M | 34.24% | 3.61% |
| VIDA VENTURES ADVISORS, LLC | 10/08/2024 | 3.93 M | $62.87 M | 0.00% | 3.38% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 3.56 M | $56.86 M | 326.39% | 3.06% |
| SIREN, L.L.C. | 11/13/2024 | 3.26 M | $52.11 B | 100.00% | 2.80% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 3.22 M | $51.55 M | -43.58% | 2.77% |
| FMR LLC | 11/13/2024 | 2.92 M | $46.63 M | 4.64% | 2.51% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 2.89 M | $46.22 M | 0.00% | 2.49% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.81 M | $45.00 M | 41.00% | 2.42% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 2.72 M | $43.42 M | 54.12% | 2.34% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 2.56 M | $40.96 M | 58.95% | 2.20% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 2.30 M | $38.36 M | 99.06% | 1.98% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.16 M | $34.57 M | 3.33% | 1.86% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 2.13 M | $34.09 M | 100.00% | 1.83% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 2.01 M | $32.17 M | -14.20% | 1.73% |
| MORGAN STANLEY | 11/14/2024 | 1.38 M | $22.06 M | -32.71% | 1.19% |
| COMMODORE CAPITAL LP | 11/14/2024 | 1.35 M | $21.59 M | 100.00% | 1.16% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 1.35 M | $21.59 M | 100.00% | 1.16% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 1.29 M | $20.70 M | 100.00% | 1.11% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 1.29 M | $20.55 M | 3.21% | 1.11% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 1.23 M | $19.62 M | 123.44% | 1.06% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 1.14 M | $18.22 M | 21.86% | 0.98% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 965,612 | $15.44 M | -14.98% | 0.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 744,592 | $11.91 M | 100.00% | 0.64% |
| TANAGER WEALTH MANAGEMENT LLP | 10/22/2024 | 696,096 | $11.13 M | 0.00% | 0.60% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 681,421 | $10.90 M | -33.40% | 0.59% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 640,000 | $10.23 M | 100.00% | 0.55% |
| CITADEL ADVISORS LLC | 11/14/2024 | 587,518 | $9.39 M | 1,434.95% | 0.51% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 559,720 | $8.95 M | 100.00% | 0.48% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 558,714 | $8.82 M | 73.96% | 0.48% |
| WOODLINE PARTNERS LP | 11/14/2024 | 516,379 | $8.26 M | 318.25% | 0.44% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 512,647 | $8.20 M | 13.92% | 0.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/08/2024 | 429,701 | $6.87 M | -13.35% | 0.37% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 400,000 | $6.40 M | 100.00% | 0.34% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 313,338 | $5.01 M | 327.61% | 0.27% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 309,614 | $4.95 M | 100.00% | 0.27% |
| LORD, ABBETT & CO. LLC | 12/13/2024 | 269,205 | $4.31 M | 100.00% | 0.23% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 269,158 | $4.30 M | -57.66% | 0.23% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 264,969 | $4.24 M | 88.06% | 0.23% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 255,000 | $4.08 M | 100.00% | 0.22% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 230,379 | $3.68 M | 365.55% | 0.20% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 209,600 | $3.35 M | 20.67% | 0.18% |
| MARSHALL WACE, LLP | 11/14/2024 | 180,853 | $2.89 M | -19.60% | 0.16% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2024 | 177,553 | $2.84 M | 1,515.15% | 0.15% |
| JANE STREET GROUP, LLC | 11/15/2024 | 177,260 | $2.83 M | 100.00% | 0.15% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 170,951 | $2.73 M | 290.76% | 0.15% |
Centessa Pharmaceuticals plcinstitutional Ownership - FAQ's
During the previous two years, 114 institutional investors and hedge funds held shares of Centessa Pharmaceuticals plc. The most heavily invested institutionals were:
Medicxi Ventures Management (Jersey) Ltd: 19.96 M
GENERAL ATLANTIC, L.P.: 9.68 M
PERCEPTIVE ADVISORS LLC: 6.28 M
First Light Asset Management, LLC: 5.94 M
PRICE T ROWE ASSOCIATES INC /MD/: 4.68 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 4.2 M
93.39% of Centessa Pharmaceuticals plc stock is owned by institutional investors.
Institutional investors have bought a total of 121.92 M shares in the last 24 months. This purchase volume represents approximately $2.09 B in transactions.